Sarah Gheuens - Sep 21, 2023 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Director
Signature
/s/ Lara Meisner, Attorney-in-Fact for Sarah Gheuens
Stock symbol
VRDN
Transactions as of
Sep 21, 2023
Transactions value $
$0
Form type
4
Date filed
9/25/2023, 04:35 PM
Previous filing
Jul 6, 2023
Next filing
Jan 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +40K $0.00 40K Sep 21, 2023 Common Stock 40K $15.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 36 equal monthly installments, subject to the Reporting Person's continued service to Issuer through each vesting date.